Business
BioSpectrum Asia
Global Harmonization Working Party re-elects Taiwan FDA to Chair medical devices regulation
The Taiwan Food and Drug Administration (TFDA) has been re-elected as Chair of the Global Harmonization Working Party (GHWP) Working Group 3 (WG3) on Pre-market: Software as a Medical Device (SaMD).
1 min |
BioSpectrum Asia March 2026
BioSpectrum Asia
"I see leadership as a multiplier effect. When individuals grow, organisations and communities advance"
For International Women's Day, we spotlight women leaders shaping the future of healthcare across the region. Among them is Evelyn Pang, General Manager of Moderna Singapore and Hong Kong.
4 min |
BioSpectrum Asia March 2026
BioSpectrum Asia
Monash University and Thermo Fisher introduce Catalyst PhD programme
Australia's Monash University and US-based Thermo Fisher Scientific have launched the Catalyst PhD programme - a new industry partnership designed to apply doctoral-level research skills directly to real-world business challenges.
1 min |
BioSpectrum Asia March 2026
BioSpectrum Asia
WHO launches handbook to strengthen global STI response
The World Health Organization (WHO) has released its first-ever consolidated operational handbook on sexually transmitted infections (STIs), to help countries urgently strengthen the prevention, diagnosis, treatment and care of STIs across health systems.
1 min |
BioSpectrum Asia March 2026
BioSpectrum Asia
MakeO announces acquisition of Zenyum to build Asia's largest consumer dental tech platform
The transaction positions Toothsi as a pan-Asian leader in clear aligner technology, orthodontics and consumer oral-care products, with India as the strategic and manufacturing hub for the combined business.
1 min |
BioSpectrum Asia March 2026
BioSpectrum Asia
W Health Ventures announces initial close of Fund II at Rs 550 Cr
W Health Ventures has announced the initial close of Fund II at Rs 550 crore, aiming toward a target of Rs 630 crore.
1 min |
BioSpectrum Asia March 2026
BioSpectrum Asia
Investing in women's health is investing in Southeast Asia's future
Since joining Roche Malaysia in 2021 as General Manager, Deepti Saraf has steered the organisation through a pivotal chapter for healthcare. At the height of the COVID-19 pandemic, her immediate priority was safeguarding uninterrupted treatment access by reinforcing supply chains and supporting healthcare providers on the frontlines. As systems transitioned into recovery, her focus evolved toward long-term transformation—particularly in breast cancer care. In an interview with BioSpectrum Asia, Deepti shares her perspective on evolving healthcare priorities, the persistent barriers to early detection, and how patient-centric strategies, cross-sector collaboration, and Malaysia’s growing role as a regional innovation hub can help strengthen cancer care systems across Southeast Asia. Edited excerpts:
6 min |
BioSpectrum Asia March 2026
BioSpectrum Asia
CARsgen injects RMB 370 M to expand CAR-T commercial manufacturing base in Shanghai
CARsgen Therapeutics, a company focused on developing innovative CAR T-cell therapies, has announced that through its indirectly whollyowned subsidiary CARsgen Diagnostics, it has signed Strategic Cooperation Agreements with Shanghai Jingong Enterprise, which is a key platform enterprise in the Bay Area High-Tech Zone of Jinshan District, Shanghai.
1 min |
BioSpectrum Asia March 2026
BioSpectrum Asia
Daiichi Sankyo collaborates with BostonGene to accelerate AI-based drug development
US-based BostonGene, the developer of the leading AI foundation model for tumour and immune biology, has announced a strategic collaboration with Japanese pharmaceutical firm Daiichi Sankyo.
1 min |
BioSpectrum Asia March 2026
BioSpectrum Asia
Galux raises $29 M to advance Al-driven protein design for drug discovery
Galux, a South Korea-based biotech startup pioneering artificial intelligence (AI)-driven protein therapeutics design, has announced the successful completion of a $29 million (KRW 42 billion) Series B financing.
1 min |
BioSpectrum Asia March 2026
BioSpectrum Asia
Diversity will make us more creative and powerful, while also creating a more equitable leadership pathway for life science companies
In an interview with BioSpectrum Asia, Jieun Shin, Executive Vice President and Head of the Manufacturing Division at Samsung Bioepis shares candid insights into the challenges she has navigated on her path to senior leadership, and her advice for women seeking to advance in science and manufacturing.
2 min |
BioSpectrum Asia March 2026
BioSpectrum Asia
Roche launches AI-enabled predictive CGM solution for diabetes management in Middle East
Roche Diagnostics Middle East recently presented a landmark launch event revealing Accu-Chek SmartGuide, a breakthrough Continuous Glucose Monitoring (CGM) innovation that sets a new standard of care for diabetes management in the Middle East.
1 min |
BioSpectrum Asia March 2026
BioSpectrum Asia
Innovent inks $8.5 B deal with Eli Lilly for oncology and immunology-based medicines
China-based Innovent Biologics, Inc. has announced a strategic collaboration with Eli Lilly and Company, in the US, to advance novel medicines in oncology and immunology.
1 min |
BioSpectrum Asia March 2026
BioSpectrum Asia
New Zealand improves access to new ADHD prescribing rules
As of February 1, 2026, changes to New Zealand's prescribing rules for Attention-Deficit Hyperactivity Disorder (ADHD) stimulant medicines have come into effect, expanding who can assess, diagnose and start people on treatment.
1 min |
BioSpectrum Asia March 2026
BioSpectrum Asia
Zuellig Pharma acquires brands from Bayer to strengthen consumer healthcare portfolio
Singapore-headquartered Zuellig Pharma has acquired all rights, title, and interest in and to the Zam-Buk and Vapex consumer healthcare brands from Bayer Consumer Care AG for Thailand, Singapore, Indonesia, Malaysia and Brunei.
1 min |
BioSpectrum Asia March 2026
BioSpectrum Asia
Korea supports rapid growth of biopharma companies through global collaboration
The Ministry of Health and Welfare (MoHW), South Korea government, and the Korea Health Industry Development Institute (KHIDI) are recruiting participating companies for the 2026 Global Leading Company Collaboration Programme (K-Biopharma Next Bridge) to promote global open innovation in the pharmaceutical and biotechnology sectors.
1 min |
BioSpectrum Asia March 2026
BioSpectrum Asia
Kyorin and Lunatus partner to launch Lasvic tablets in 9 Middle Eastern countries
Japan's Kyorin Pharmaceutical has entered into an exclusive distribution agreement with Lunatus Marketing & Consulting FZCO for Lasvic tablets (Lascufloxacin hydrochloride).
1 min |
BioSpectrum Asia Feb 2026
BioSpectrum Asia
Biotium launches GlycoLiner Cell Surface Glycoprotein Labeling Kits
US-based Biotium, a leading innovator in fluorescent dyes and life science reagents, has announced the launch of GlycoLiner Cell Surface Glycoprotein Labeling Kits for rapid, selective, and covalent labeling of cell surface glycoproteins.
1 min |
BioSpectrum Asia Feb 2026
BioSpectrum Asia
Vaxxas appoints former Merck Global Vaccines President David Peacock as CEO
Australia-based Vaxxas has announced the appointment of global biopharmaceutical executive David Peacock as Chief Executive Officer (CEO) to lead the commercialisation of the company's proprietary high-density microarray patch (HD-MAP) vaccination technology.
1 min |
BioSpectrum Asia Feb 2026
BioSpectrum Asia
Thermo Fisher partners with NVIDIA leveraging AI to advance scientific instrumentation
US-based Thermo Fisher Scientific Inc. has announced a strategic collaboration with NVIDIA to power artificial intelligence (AI)based solutions and laboratory automation at scale.
1 min |
BioSpectrum Asia Feb 2026
BioSpectrum Asia
Bruker consolidates ownership of TOFWERK in expansion of mass spectrometry portfolio
Bruker Corporation has announced the acquisition of an additional 60 per cent ownership stake in TOFWERK AG, a Switzerland-based innovator in ultra-fast time-of-flight (TOF) mass spectrometry technology for small molecule applied markets, consolidating Bruker's ownership to 100 per cent.
1 min |
BioSpectrum Asia Feb 2026
BioSpectrum Asia
Bioengineered tissue by Japan emerges as revolutionary treatment for secondary lymphedema
A research team led by Associate Professor Kosuke Kusamori from the Faculty of Pharmaceutical Sciences at Tokyo University of Science (TUS), Japan, is pioneering an innovative technique for lymphatic tissue engineering that could revolutionize the treatment of secondary lymphedema.
1 min |
BioSpectrum Asia Feb 2026
BioSpectrum Asia
Chitose and Fujifilm Biosciences to drive global innovation and biopharma manufacturing
Japan-based Chitose Laboratory Corp. & Fujifilm Biosciences Inc. have announced a new strategic alliance that leverages the strengths of both companies in advancing biopharmaceutical production.
1 min |
BioSpectrum Asia Feb 2026
BioSpectrum Asia
Vibrant Therapeutics on-boards Dr Han Lee as Co-CEO
Vibrant Therapeutics, a clinical-stage biotechnology company based in China and US, has announced the appointment of Dr Han Lee as co-chief executive officer (CEO).
1 min |
BioSpectrum Asia Feb 2026
BioSpectrum Asia
IIT-D and AIIMS develop swallowable microdevice for microbiome study
Researchers at the Indian Institute of Technology (IIT) Delhi, and All India Institute of Medical Sciences (AIIMS) have developed an ingestible device that can sample bacteria directly from the small intestine, opening a new window into the human gut microbiome.
1 min |
BioSpectrum Asia Feb 2026
BioSpectrum Asia
Ambitious research to develop multivalent vaccines against multiple deadly filoviruses
Scientists at the University of Oxford, in collaboration with partners, will spearhead the development of new vaccines that aim to provide comprehensive protection against multiple lethal filoviruses, including Ebola virus, Sudan virus, Bundibugyo virus, and Marburg virus.
1 min |
BioSpectrum Asia Feb 2026
BioSpectrum Asia
Korea opens door to B cell-based personalised cancer vaccines
Researchers from the Department of Bio and Brain Engineering at Korea Advanced Institute of Science and Technology (KAIST), in collaboration with Neogen Logic Co., have developed a new artificial intelligence (AI) model to predict neoantigens, a core element of personalised cancer vaccine development, and clarified the importance of B cells in cancer immunotherapy.
1 min |
BioSpectrum Asia Feb 2026
BioSpectrum Asia
JNCASR and CrisprBits to set up CRISPR Centre of Excellence in Innovation and Translation
A Letter of Intent (LOI) has been signed for the establishment of CRISPR Centre of Excellence for Innovation & Translation (CoE-CIT).
1 min |
BioSpectrum Asia Feb 2026
BioSpectrum Asia
Beckman Coulter Life Sciences unveils Biomek i3 Benchtop Liquid Handler
Beckman Coulter Life Sciences, a Danaher company and a global leader in laboratory automation and innovation, makes liquid handling research more accessible with the launch of the Biomek iz Benchtop Liquid Handler.
1 min |
BioSpectrum Asia Feb 2026
BioSpectrum Asia
Chad May steps in as Chief Scientific Officer at Orum Therapeutics
Orum Therapeutics, a biotechnology company based in the US and South Korea, has announced the appointment of Dr Chad May as Chief Scientific Officer (CSO).
1 min |